Materials And Products Tenders

Procurement of a Roll-Off Container for Preparation Material

Framework Agreement Temporary Cable System

Mkf M330 Procurement Linear Accelerator 2

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Lanreotide, Atc H01cb03 (Obo) for the Period November 1St, 2024 - October 31St, 2025 (Plus Extension Option 1X12 Months)

Open House Drug Discount Agreements Sarilumab, Atc L04ac14

Open House Drug Discount Contracts Piribedil, Atc N04bc08

Open House Drug Discount Agreements Denosumab, Atc M05bx04

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Thalidomide, Atc L04ax02 (Obg) for the Period November 1St, 2024 - October 31St, 2026

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Filgotinib (L04af04) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Filgrastim (L03aa02) as Part of a So-Called Open House Model.